iSpecimen to buy Foldlab AI software assets for $4.5 million cash and stock
ISPC•iSpecimen signs asset purchase agreement for Foldlab AI software assets
iSpecimen entered an asset purchase agreement on Sept. 4, 2026 to buy AI software and related intellectual property from Foldlab AI.
Assets include a Disease-Associated Protein Discovery AI Agent and a Disease Trend Prediction and Monitoring AI Model.
Purchase price set at USD 4.5 million, including USD 2 million cash; USD 1.25 million depends on product delivery and acceptance.
Closing hinges on shareholder vote, Nasdaq clearance for the share issuance, regulatory consents, and other customary conditions.
Transaction expected to close promptly once shareholder approval is secured.
